Abstract
Purpose
The aim of this study has been to evaluate the physical, psychological, and social well-being in a large group of Sardinian adult patients with transfusion-dependent beta-Thalassemia when compared with a group of healthy subjects of the same age and geographical extraction.
Methods
Male or female patients ≥ 18 years of age with Thalassemia major on regular transfusion at Thalassemia Center in Cagliari (Italy) were requested to complete the World Health Organization Quality of life-BREF (WHOQOL-BREF) questionnaire. The WHOQOL-BREF was also made available online to age- and sex-matched non-thalassemic adult subjects living in Sardinia.
Results
Two hundred and seven subjects with Thalassemia were invited to participate in the study. The questionnaire was also completed by 211 age- and sex-matched non-thalassemic subjects living in Sardinia. Scores suggestive of a good quality of life were obtained in all the areas investigated. Thalassemia patients had scores at least as good as those of non-thalassemic subjects in all items and the percentage of those with a score ≥ 60 was higher among patients. The analysis of demographic actually highlights that the disease has a little effect on their personal and social lives. There was a positive association between subjective well-being and effective clinical conditions. Moreover, the association between health perception and adherence to treatment suggests that compliance with treatment contributes to the well-being of the patient, both physically and psychologically.
Conclusions
Adult subjects with Thalassemia who live in Western countries have a good quality of life in accordance with the advances in the management of the disease.
Similar content being viewed by others
References
Cappellini, M. D., Cohen, A., Porter, J., Taher, A., & Viprakasit, V. (Eds.). (2014). Guidelines for the management of transfusion dependent Thalassaemia (TDT) [Internet] (3rd edn.). Nicosia (CY): Thalassaemia International Federation.
Rund, D. (2016). Thalassemia 2016: Modern medicine battles an ancient disease. American Journal of Hematology, 91(1), 15–21. https://doi.org/10.1002/ajh.24231.
Sankaran, V. G., & Nathan, D. G. (2010). Thalassemia: an overview of 50 years of clinical research. Hematology/Oncology Clinics of North America 24(6), 1005–1020. https://doi.org/10.1016/j.hoc.2010.08.009.
Borgna-Pignatti, C., Rugolotto, S., De Stefano, P., Zhao, H., Cappellini, M. D., Del Vecchio, G. C., et al. (2004). Survival and complications in patients with Thalassemia major treated with transfusion and deferoxamine. Haematologica, 89(10), 1187–1193.
Modell, B., Khan, M., Darlison, M., Westwood, M. A., Ingram, D., & Pennell, D. J. (2008). Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance, 10, 42. https://doi.org/10.1186/1532-429X-10-42.
Telfer, P., Coen, P. G., Christou, S., Hadjigavriel, M., Kolnakou, A., Pangalou, E., et al. (2006). Survival of medically treated Thalassemia patients in Cyprus. Trends and risk factors over the period 1980–2004. Haematologica, 91(9), 1187–1192.
Origa, R., Piga, A., Quarta, G., Forni, G. L., Longo, F., Melpignano, A., et al. (2010). Pregnancy and beta-Thalassemia: An Italian multicenter experience. Haematologica, 95(3), 376–381. https://doi.org/10.3324/haematol.2009.012393.
Sankaran, V. G., & Weiss, M. J. (2015). Anemia: progress in molecular mechanisms and therapies. Nature Medicine, 21(3), 221–230. https://doi.org/10.1038/nm.3814.
Bazi, A., Sargazi-Aval, O., Safa, A., & Miri-Moghaddam, E. (2017). Health-related quality of life and associated factors among Thalassemia major patients, Southeast of Iran. Journal of Pediatric Hematology/Oncology, 39(7), 513–517. https://doi.org/10.1097/MPH.0000000000000963.
Tuysuz, G., & Tayfun, F. (2017). Health-related quality of life and its predictors among transfusion-dependent Thalassemia patients. Journal of Pediatric Hematology/Oncology, 39(5), 332–336. https://doi.org/10.1097/MPH.0000000000000790.
Amid, A., Saliba, A. N., Taher, A. T., & Klaassen, R. J. (2015). Thalassaemia in children: From quality of care to quality of life. Archives of Disease in Childhood, 100(11), 1051–1057. https://doi.org/10.1136/archdischild-2014-308112.
Ansari, S., Baghersalimi, A., Azarkeivan, A., Nojomi, M., & Hassanzadeh Rad, A. (2014). Quality of life in patients with Thalassemia major. Iranian Journal of Pediatric Hematology and Oncology, 4(2), 57–63.
Gan, G. G., Hue, Y. L., & Sathar, J. (2016). Factors affecting quality of life in adult patients with Thalassaemia major and intermedia. Annals of the Academy of Medicine, Singapore, 45(11), 520–523.
Soni, S., Thawani, R., Idhate, T., Kalra, M., & Mahajan, A. (2016). Health related quality of life in patients with transfusion-dependent Thalassemia. Indian Pediatrics, 53(8), 741–742.
The WHOQOL Group (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551–558.
Lyrakos, G. N., Vini, D., Aslani, H., & Drosou-Servou, M. (2012). Psychometric properties of the specific Thalassemia quality of life instrument for adults. Patient Preference and Adherence, 6, 477–497. https://doi.org/10.2147/PPA.S30763.
Keowmani, T., & Lee, L. W. (2016). Failure to replicate the internal structure of Greek-specific Thalassemia quality of life instrument in adult Thalassemia patients in Sabah. Patient Preference and Adherence, 10, 205–211. https://doi.org/10.2147/PPA.S96880.
WHO (1996). WHOQOL-BREF introduction, administration and scoring, field trial version. Geneva: World Health Organization.
Wood, J. C., Enriquez, C., Ghugre, N., Tyzka, J. M., Carson, S., Nelson, M. D., et al. (2005). MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent Thalassemia and sickle cell disease patients. Blood, 106(4), 1460–1465. https://doi.org/10.1182/blood-2004-10-3982.
Bland, J. M., & Altman, D. G. (1997). Cronbach’s alpha. BMJ, 314(7080), 572.
Barbosa Silva, P. A., Soares, S. M., Guimarães Santos, G. F., & Barbosa Silva, L. (2014). Cut-off point for WHOQOL-bref as a measure of quality of life of older adults. Revista de saude publica, 48(3), 390–397. https://doi.org/10.1590/S0034-8910.2014048004912.
Safizadeh, H., Farahmandinia, Z., Nejad, S. S., Pourdamghan, N., & Araste, M. (2012). Quality of life in patients with Thalassemia major and intermedia in kerman-iran (I.R.). Mediterranean Journal of Hematology and Infectious Diseases, 4(1), e2012058. https://doi.org/10.4084/MJHID.2012.058.
La Nasa, G., Caocci, G., Efficace, F., Dessì, C., Vacca, A., Piras, E., et al. (2013). Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for Thalassemia. Blood, 122(13), 2262–2270. https://doi.org/10.1182/blood-2013-05-502658.
Haghpanah, S., Vahdati, S., & Karimi, M. (2017). Comparison of quality of life in patients with β-Thalassemia intermedia and β-Thalassemia major in Southern Iran. Hemoglobin, 41(3), 169–174. https://doi.org/10.1080/03630269.2017.1340307.
Taher, A. T., Musallam, K. M., Karimi, M., El-Beshlawy, A., Belhoul, K., Daar, S., et al. (2010). Overview on practices in Thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: The OPTIMAL CARE study. Blood, 115(10), 1886–1892. https://doi.org/10.1182/blood-2009-09-243154.
Amid, A., Leroux, R., Merelles-Pulcini, M., Yassobi, S., Saliba, A. N., Ward, R., Karimi, M.,., Taher, A. T., Klaassen, R. J., & Kirby-Allen, M. (2016). Factors impacting quality of life in Thalassemia patients; results from the Intercontinenthal Collaborative Study. Blood, 128, 3633.
Clouet, F., Excler-Cavailher, G., Christophe, B., Masson, F., & Fasquel, D. (2001). Type 2 diabetes and short form 36-items health survey. Diabetes & Metabolism, 27(6), 711–717.
WHO (2005). Constitution of the World Health Organization. In World Health Organization, Basic documents (45th edn). Geneva: World Health Organization.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Floris, F., Comitini, F., Leoni, G. et al. Quality of life in Sardinian patients with transfusion-dependent Thalassemia: a cross-sectional study. Qual Life Res 27, 2533–2539 (2018). https://doi.org/10.1007/s11136-018-1911-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-018-1911-7